MedPath

蓝耘智合生物科技有限责任公司

Ownership
-
Established
2018-09-28
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

51

NMPA:51

Drug Approvals

消癌平片

Approval Number
国药准字Z20083253
Approval Date
Mar 5, 2023
NMPA

跌打损伤丸

Approval Number
国药准字Z37021252
Approval Date
Dec 13, 2019
NMPA

桂附地黄丸

Approval Number
国药准字Z37021115
Approval Date
Dec 13, 2019
NMPA

人参归脾丸

Approval Number
国药准字Z37021094
Approval Date
Dec 13, 2019
NMPA

六味地黄丸

Approval Number
国药准字Z37021053
Approval Date
Dec 13, 2019
NMPA

牛黄解毒片

Approval Number
国药准字Z37021071
Approval Date
Dec 13, 2019
NMPA

加味藿香正气丸

Approval Number
国药准字Z37021027
Approval Date
Dec 13, 2019
NMPA

人参归脾丸

Approval Number
国药准字Z37021095
Approval Date
Dec 13, 2019
NMPA

橘红丸

Approval Number
国药准字Z37021257
Approval Date
Dec 13, 2019
NMPA

人参健脾丸

Approval Number
国药准字Z37021376
Approval Date
Dec 13, 2019
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.